Results 201 to 210 of about 16,895 (259)

Quantitative Evaluation of Cardiac Function Improvement by Conventional Cardiology Drug Regimens Combined with Sacubitril/Valsartan Sodium in Heart Failure Patients. [PDF]

Int J Gen Med
Liu C, Lai C, Xu M, Wang Y.
europepmc   +1 more source

Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure. [PDF]

ESC Heart Fail
Jung MH, Cho DH, Choi J, Kim MN, Lee CJ, Son JW, Kim Y, Youn JC, Yoo BS.   +8 more
europepmc   +1 more source

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial. [PDF]

Circulation
Omland T, Heck SL, Holte E, Lilleaasen AM, Gynnild MN, Fagerland MW, Vinje-Jakobsen V, Næs AL, Blix ES, Larsen AI, Geisler J, Gulati G, Wethal T.   +12 more
europepmc   +1 more source

On-treatment blood pressure and dose-dependent effects of ARNI in heart failure with reduced ejection fraction: Insights from a multicenter registry. [PDF]

PLoS One
Park J, Park CS, Rhee TM, Choi HJ, Choi HM, Lee HJ, Park JB, Yoon YE, Lee SP, Kim YJ, Cho GY, Kim HK, Hwang IC.   +12 more
europepmc   +1 more source

Angiotensin Receptor-Neprilysin Inhibitors and Mortality Among Patients With HFrEF

Henrik Svanström, George Frederick Mkoma, Anders Hviid, Björn Pasternak   +3 more
openalex   +1 more source

Real-World Evaluation of the Dosage Patterns and Safety of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Indian Patients With Heart Failure With Reduced Ejection Fraction: The ADD-ARNI Study Protocol. [PDF]

Cureus
Mittal S, Mehta A, Sharma K, Jayagopal PB, Pande A, Sugumaran A, Sawant S, Mohanasundaram S.   +7 more
europepmc   +1 more source

Impact of Insurance Status and Region on Angiotensin Receptor–Neprilysin Inhibitor Prescription During Heart Failure Hospitalizations

Giovanni Davogustto, Quinn S. Wells, Frank E. Harrell, Stephen J. Greene, Dan M. Roden, Lynne W. Stevenson   +5 more
openalex   +1 more source

Impact of Sacubitril/Valsartan (ARNI) Compared with ACEI/ARB in Patients with Acute Myocardial Infarction on Post-Infarction Left Ventricular Systolic Dysfunction: A Retrospective Analysis. [PDF]

Biomedicines
Niemiec R, Niemiec M, Nowak M, Gurba B, Bujak M, Chowaniec-Rybka K, Sowier M, Nowotarska A, Gruchlik B, Pytlewski A, Mizia-Stec K.   +10 more
europepmc   +1 more source

The Role of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. [PDF]

JACC Adv
Tzoumas A, Tapp D, Crousillat D, Honigberg MC, Rodriguez-Lozano PF, Aggarwal NR, Ebong IA, Briller J, De Oliveira GM, Harrington CM, Mohammed SF, Merz NB, Henry TD, Quesada O, ACC Cardiovascular Disease in Women Committee.   +14 more
europepmc   +1 more source

Evaluating Role of ARNI (Angiotensin Receptor Neprilysin Inhibitor) in Patients of Heart Failure with Mildly Reduced Ejection Fraction (HFmrEF) with LBBB (Left Bundle Branch Block) in baseline ECG and Jerky Septal Motion in ECHO: A Prospective Small Observational Study

Suvadeep Biswas, Biswajit Majumder, Somnath Maji, Ratul Ghosh   +3 more
openalex   +1 more source